Welcome to the PART Trial | PART: Partial prostate Ablation versus Radical prosTatectomy

University of Oxford

University of Oxford (PART Study Sponsor)
Freddie Hamdy

Prof. Freddie Hamdy, PART Study Chief Investigator
NDS

World Class Research at Oxford University
PART Trial

New Technologies
CRUK

For up to date, accurate information on prostate cancer, visit Cancer Research UK's patient information website
SITU

Surgical Intervention Trials Unit (SITU)

PART Full Trial is coming soon!

Phase III RCT with long-term follow-up.

800 men to be recruited over 5 years in at least 15 NHS Urology departments.

Participant will be randomised to either Radical treatment (RP, RRT or LDR-B) or Partial ablation using Vascular Targeted Photodynamic Therapy (VTP).

Participant Update

Recruitment Progress:

KEY PEOPLE

Image (c) PART Trial

Prof Freddie Hamdy (Chief Investigator) Contact here.

Elsa Mauricio Reus (Clinical Trial Manager) Contact here.

To see which sites are involved in PART click here.

SPONSOR & FUNDER

Image (c) PD

Sponsor: University of Oxford

Funding Acknowledgement:
This project was funded by the National Institute for Health Research Health Technology Assessment Programme (project number 12/35/54).

USEFUL LINKS

Image (c) PD

Click here for a short overview of the PART study.

Click here to see PART study on ISRCTN.

Click to view information about PART study from NIHR database.

Click here for the Cancer Research UK website.

Click here for the Prostate Cancer UK website.

Click here to see the PART Study recruitment advertisement on Oxford University Hospitals NHS Foundation Trust website.